[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100602602":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":7,"responsibleParty":18,"collaborators":7,"id":22,"slug":23,"hasResults":24,"nctId":25,"briefTitle":26,"officialTitle":27,"acronym":7,"eligibilityCriteria":28,"healthyVolunteers":24,"sex":29,"minAge":30,"maxAge":7,"enrollmentInfo":31,"targetDuration":7,"studyType":34,"phases":7,"briefSummary":35,"conditions":36,"keywords":41,"overallStatus":49,"whyStopped":7,"lastUpdateSubmitDate":50,"lastUpdatePostDateStruct":51,"startDateStruct":54,"completionDateStruct":56,"leadSponsor":58,"locationsCount":7},{"fullName":5,"class":6},"Assiut University","OTHER",null,[9,14],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Abdulrahman Antar, Resident Doctor","CONTACT","+201553600089","AbdElrahman.17289792@med.aun.edu.eg",{"name":15,"role":11,"phone":16,"phoneExt":7,"email":17},"Abdelhamid Mohamed, Lecturer","+201012125291","Abdon33@aun.edu.eg",{"type":19,"investigatorFullName":20,"investigatorTitle":21,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Abdulrahman Antar Mohamed","Dr","100602602","gastrointestinal-bleeding-is-blood-loss-in-the-digestive-tract-classified-as-upper-or-lower-ischemic-heart-disease-is-due-to-blocked-heart-arteries-antiplatelet-drugs-help-prevent-heart-attacks-but-increase-gi-bleeding-risk-especially-when-used-together-as-dual-therapy-100602602",false,"NCT07125651","Gastrointestinal Bleeding is Blood Loss in the Digestive Tract, Classified as Upper or Lower. Ischemic Heart Disease is Due to Blocked Heart Arteries. Antiplatelet Drugs Help Prevent Heart Attacks But Increase GI Bleeding Risk, Especially When Used Together as Dual Therapy.","Prevalence of Gastrointestinal Bleeding in Ischemic Heart Disease Patients Undergoing Single Compared to Dual Antiplatelet Treatment","Inclusion Criteria:\n\n* Patients (aged 18 years old and older) who were diagnosed ischemic heart disease on single or dual antiplatelet therapy and developed gastrointestinal bleeding (manifestation of hematemesis, melena or bleeding per rectum).\n\nExclusion Criteria:\n\n* Patients on anticoagulant.\n* Patients with bleeding tendencies.\n* Individuals with other comorbidities.\n* patients with acute coronary syndrome.\n* Uncooperative patients.","ALL","18 Years",{"count":32,"type":33},112,"ESTIMATED","OBSERVATIONAL","Gastrointestinal bleeding is blood loss in the digestive tract, classified as upper or lower. Ischemic heart disease is due to blocked heart arteries. Antiplatelet drugs help prevent heart attacks but increase GI bleeding risk, especially when used together as dual therapy. This study aims to compare the prevalence and risk of gastrointestinal bleeding in ischemic heart disease patients on single versus dual antiplatelet therapy, and to explore strategies for reducing gastrointestinal bleeding in these patients, enhancing treatment safety without compromising cardiovascular protection.",[37,38,39,40],"Gastro Intestinal Bleeding","Ischaemic Heart Diseases","Antiplatelet Drugs","Antiplatelet Drug-related Gastrointestinal Injury",[42,43,44,45,46,47,48],"Gastrointestinal bleeding","GIB","ischemic heart disease","IHD","Antiplatelet therapy","SAPT","DAPT","NOT_YET_RECRUITING","2025-08-10",{"date":52,"type":53},"2025-08-15","ACTUAL",{"date":55,"type":33},"2025-09-01",{"date":57,"type":33},"2026-10",{"name":5,"class":6}]